2026 NPPES data Endocrinology, Diabetes & Metabolism Physician NPI 1982021226 M.D.
Verify on CMS →

DAISY DUAN, M.D.

Endocrinology, Diabetes & Metabolism Physician in BALTIMORE, Maryland. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
423
Medicare Part D claims · 60 beneficiaries · Endocrinology, Diabetes & Metabolism Physician avg: 3K
Generic prescribing
48%
generic claims · 52% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
74.3962/100
▼ 9 pts below national avg 83.1 · [object Object]
What the federal data reveals: DAISY DUAN, M.D. is a Endocrinology, Diabetes & Metabolism Physician ([object Object]) practicing in BALTIMORE, Maryland with a Medicare Part D prescribing footprint of 423 claims across 60 beneficiaries — 52% brand-name prescribing . Their CMS MIPS Final Score of 74.3962/100 (national average: 83.1) reflects performance across Quality, Cost, Interoperability, and Improvement Activities .

What stands out: DAISY DUAN, M.D. reported a CMS MIPS final score of 74.3962 out of 100, below the 83.1 national average, and filed 423 Medicare Part D claims in 2023. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

Board certification likely (heuristic — not verified)

DAISY DUAN, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 2 hospital affiliations — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

DAISY DUAN, M.D. at a glance

Below national average

NPI registry status

Active

Issued 03/25/2014

NPI 1982021226

Primary specialty

Endocrinology, Diabetes & Metabolism Physician

Mid-sized

7,852 US NPIs in this specialty

Medicare Part D claims

423 84% vs specialty avg

2023 prescription claims

Specialty avg: 2,639

MIPS final score

74.3962/100 8.703800000000001% pts

Mid-tier band

vs 83.1 national avg

Specialty distribution in Maryland

How Endocrinology, Diabetes & Metabolism Physician compares to other specialties among Maryland providers

Maryland providers

Endocrinology, Diabetes & Metabolism Physician share within Maryland

1. Endocrinology, Diabetes & Metabolism Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Endocrinology, Diabetes & Metabolism Physician share within Maryland

Medicare quality performance — MIPS

DAISY DUAN, M.D.'s 2023 MIPS final score plotted against the Endocrinology, Diabetes & Metabolism Physician national average

Below national average
MIPS Final Score
74.3962/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Endocrinology, Diabetes & Metabolism Physician) — 74.3962/100 vs national avg 83.1

0%100%National avg83%74.4%
MIPS final score (Endocrinology, Diabetes & Metabolism Physician) — 74.3962/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

DAISY DUAN, M.D. is a Endocrinology, Diabetes & Metabolism Physician provider practicing in BALTIMORE, Maryland, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: M.D.. NPI: 1982021226. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

DAISY DUAN, M.D. appears in the CMS NPPES registry as a Endocrinology, Diabetes & Metabolism Physician provider holding M.D. credentials at 600 N WOLFE ST BLDG, BALTIMORE, MD, 21287, with a listed phone of (410) 955-3921. NPI 1982021226 was issued on 03/25/2014. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what DUAN most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 423 prescription claims written by this provider, covering 60 Medicare beneficiaries and totaling roughly $257K in drug spend, split 52% brand-name and 48% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 74.3962/100 for the 2023 performance year (Quality 64.7185, Cost 52.4354), compared with the national average of 83.1.

Endocrinology, Diabetes & Metabolism Physician is a mid-sized specialty nationwide, with 7,852 enrolled providers across 54 states and an average of 2,639 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

600 N WOLFE ST BLDG
BALTIMORE, MD 21287

Provider Details

NPI 1982021226
Specialty Endocrinology, Diabetes & Metabolism Physician
Credentials M.D.
Gender Female
NPI Issued 03/25/2014

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

74.3962
Final Score
Avg: 83.1
64.7185
Quality
52.4354
Cost
97
Promoting Interoperability

Reporting: Group practice

Hospital and facility affiliations

Facilities where DAISY DUAN, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

JOHNS HOPKINS UNIVERSITY
BALTIMORE, MD
JOHNS HOPKINS UNIVERSITY
BALTIMORE, MD

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Brand vs generic prescribing mix · Brand-heavy

DAISY DUAN, M.D. — brand share 52.0%
Specialty average (est.)

52% brand-name claims vs 48% generic, on 423 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

423
Total Claims
$257K
Total Drug Cost
60
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
815
Total Day Supply
23,918
Brand vs Generic
52% brand / 48% generic
Brand Drug Cost
$242K
Generic Drug Cost
$4K

Patient Demographics

Average Patient Age
67.6 years
Avg HCC Risk Score
1.70
Gender Split
67% female / 33% male
Age Distribution
<65: 16, 65-74: 34, 75-84: N/A, 85+: N/A

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Ozempic
Semaglutide
50
Trulicity
Dulaglutide
31
Metformin Hcl Er
Metformin Hcl
29
Novolog Flexpen
Insulin Aspart
24
Tresiba Flextouch U-100
Insulin Degludec
23
Levothyroxine Sodium
21
Atorvastatin Calcium
19
Metformin Hcl
19
Indapamide
11
Lisinopril
11

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Endocrinology, Diabetes & Metabolism Physician Overview

How DAISY DUAN, M.D. fits within the Endocrinology, Diabetes & Metabolism Physician landscape nationally.

7,852
Endocrinology, Diabetes & Metabolism Physician Providers in US
54
States with Endocrinology, Diabetes & Metabolism Physician
2,639
Avg Claims per Provider

DAISY DUAN, M.D.'s 423 claims are below the specialty average of 2,639.

Nearby Endocrinology, Diabetes & Metabolism Physician Providers in Maryland

Other clinicians with the same primary specialty enrolled in Maryland, drawn from the same CMS NPPES roster as DUAN.

Compare Endocrinology, Diabetes & Metabolism Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is DAISY DUAN, M.D.'s specialty?
DAISY DUAN, M.D. specializes in Endocrinology, Diabetes & Metabolism Physician and practices in BALTIMORE, Maryland. Credentials: M.D..
How much does DAISY DUAN, M.D. prescribe under Medicare Part D?
In 2023, DAISY DUAN, M.D. wrote 423 Medicare Part D claims totaling $257K in drug costs for 60 beneficiaries.
What is DAISY DUAN, M.D.'s Medicare quality score?
DAISY DUAN, M.D. has a CMS MIPS Final Score of 74.3962/100 (Quality: 64.7185, Cost: 52.4354). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is DAISY DUAN, M.D. located?
DAISY DUAN, M.D. is located at 600 N WOLFE ST BLDG, BALTIMORE, MD, 21287. Phone: (410) 955-3921.
What is DAISY DUAN, M.D.'s NPI number?
DAISY DUAN, M.D.'s National Provider Identifier (NPI) is 1982021226, issued on 03/25/2014.
Does DAISY DUAN, M.D. prescribe more brand-name or generic drugs?
DAISY DUAN, M.D.'s prescribing is 52% brand-name and 48% generic drugs by claim count, with $242K in brand drug costs.
How many Endocrinology, Diabetes & Metabolism Physician providers are there in the US?
There are 7,852 Endocrinology, Diabetes & Metabolism Physician providers across 54 states in the US. The average Endocrinology, Diabetes & Metabolism Physician provider writes 2,639 Medicare Part D claims per year.
What drugs does DAISY DUAN, M.D. prescribe most often?
Based on 2023 Medicare Part D data, DAISY DUAN, M.D.'s most frequently prescribed drugs include Ozempic, Trulicity, Metformin Hcl Er. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does DAISY DUAN, M.D. accept Medicare?
DAISY DUAN, M.D. appears in CMS Medicare data with 423 Part D claims and 60 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify DAISY DUAN, M.D.'s credentials?
DAISY DUAN, M.D.'s NPI is 1982021226 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology